journal article·2021-09Open access

Emerging Targets in Type 2 Diabetes and Diabetic Complications

Sevgican Demir, Peter P. Nawroth, Stephan Herzig, Bilgen Ekim Üstünel

Advanced Science· Volume 8· Issue 18

Abstract

Abstract Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Diabetes Treatment and Management · Pancreatic function and diabetes · Natural Antidiabetic Agents Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute for Diabetes and Cancer (IDC) Helmholtz Center Munich Ingolstädter Landstr. 1 Neuherberg 85764 Germany

Joint Heidelberg ‐ IDC Translational Diabetes Program Internal Medicine 1 Heidelberg University Hospital Im Neuenheimer Feld 410 Heidelberg 69120 Germany

DZD Deutsches Zentrum für Diabetesforschung Ingolstädter Landstraße 1 Neuherberg 85764 Germany

Department of Internal Medicine 1 and Clinical Chemistry Heidelberg University Hospital Im Neuenheimer Feld 410 Heidelberg 69120 Germany

References (100+)

Show source-provided references
1. 10.4239/wjd.v7.i1.110.4239/wjd.v7.i1.1 ↗
2. Banting F. G. · Indian J. Med. Res. · 2007 · 125 · 251
3. 10.1210/er.2019-0008810.1210/er.2019-00088 ↗
4. 10.1038/nrendo.2017.15110.1038/nrendo.2017.151 ↗
5. 10.1016/S2213-8587(18)30051-210.1016/S2213-8587(18)30051-2 ↗
6. 10.1038/s41591-020-1116-910.1038/s41591-020-1116-9 ↗
7. 10.2337/diacare.26.9.260410.2337/diacare.26.9.2604 ↗
8. 10.2337/db10-119810.2337/db10-1198 ↗
9. 10.3389/fnins.2019.0052110.3389/fnins.2019.00521 ↗
10. 10.1016/j.cell.2017.04.00110.1016/j.cell.2017.04.001 ↗
11. 10.1128/MCB.05437-1110.1128/MCB.05437-11 ↗
12. 10.15252/embj.20169616410.15252/embj.201696164 ↗
13. 10.1016/j.cmet.2017.06.00610.1016/j.cmet.2017.06.006 ↗
14. 10.1507/endocrj.47.37310.1507/endocrj.47.373 ↗
15. 10.1016/j.metabol.2012.05.00710.1016/j.metabol.2012.05.007 ↗
16. 10.1371/journal.pone.012420410.1371/journal.pone.0124204 ↗
17. 10.1111/acel.1226710.1111/acel.12267 ↗
18. 10.3390/ijms2004098510.3390/ijms20040985 ↗
19. 10.1016/j.cell.2019.02.03010.1016/j.cell.2019.02.030 ↗
20. 10.1007/s00125-012-2644-810.1007/s00125-012-2644-8 ↗
21. 10.1016/j.isci.2018.06.00610.1016/j.isci.2018.06.006 ↗
22. 10.1074/jbc.M116.75264210.1074/jbc.M116.752642 ↗
23. 10.1152/ajpendo.00025.201910.1152/ajpendo.00025.2019 ↗
24. 10.1126/science.119949810.1126/science.1199498 ↗
25. 10.1128/MCB.00679-0710.1128/MCB.00679-07 ↗
26. 10.3389/fnins.2018.0041710.3389/fnins.2018.00417 ↗
27. 10.1038/ncomms1326710.1038/ncomms13267 ↗
28. 10.1172/JCI1093410.1172/JCI10934 ↗
29. 10.1074/jbc.275.12.904710.1074/jbc.275.12.9047 ↗
30. 10.18632/oncotarget.791810.18632/oncotarget.7918 ↗
31. 10.3390/cells706006310.3390/cells7060063 ↗
32. 10.3389/fendo.2018.0080210.3389/fendo.2018.00802 ↗
33. 10.1016/j.tem.2015.05.00710.1016/j.tem.2015.05.007 ↗
34. Ren L. P. · Mol. Med. Rep. · 2016 · 14 · 1649
35. 10.3390/cells905116010.3390/cells9051160 ↗
36. 10.3389/fimmu.2018.0308310.3389/fimmu.2018.03083 ↗
37. 10.1002/hep.3088710.1002/hep.30887 ↗
38. 10.1172/JCI9312310.1172/JCI93123 ↗
39. 10.1016/j.cmet.2020.11.00910.1016/j.cmet.2020.11.009 ↗
40. 10.1038/ncomms1297710.1038/ncomms12977 ↗
41. 10.1007/s00125-020-05212-610.1007/s00125-020-05212-6 ↗
42. 10.3390/nu1110243210.3390/nu11102432 ↗
43. 10.1152/physrev.00063.201710.1152/physrev.00063.2017 ↗
44. 10.1074/jbc.REV119.00835110.1074/jbc.REV119.008351 ↗
45. 10.1016/j.bbabio.2016.07.00810.1016/j.bbabio.2016.07.008 ↗
46. 10.3389/fendo.2017.0032910.3389/fendo.2017.00329 ↗
47. 10.1186/1476-511X-11-3010.1186/1476-511X-11-30 ↗
48. 10.1038/s41467-020-15963-w10.1038/s41467-020-15963-w ↗
49. 10.1038/s41467-020-19490-610.1038/s41467-020-19490-6 ↗
50. 10.15252/embr.20184725810.15252/embr.201847258 ↗
51. 10.2147/DMSO.S18660010.2147/DMSO.S186600 ↗
52. 10.1124/jpet.118.25530710.1124/jpet.118.255307 ↗
53. 10.1089/jmf.2017.410810.1089/jmf.2017.4108 ↗
54. 10.1073/pnas.152579511310.1073/pnas.1525795113 ↗
55. 10.1038/ijo.2015.20010.1038/ijo.2015.200 ↗
56. Consitt L. A. · J. Frailty Aging · 2018 · 7 · 2110.14283/jfa.2017.33 ↗
57. 10.1002/1873-3468.1274210.1002/1873-3468.12742 ↗
58. 10.1155/2016/181032710.1155/2016/1810327 ↗
59. 10.1016/j.arr.2017.10.00310.1016/j.arr.2017.10.003 ↗
60. 10.3390/molecules2509222410.3390/molecules25092224 ↗
61. 10.1038/nature2136310.1038/nature21363 ↗
62. 10.1016/j.immuni.2017.08.00910.1016/j.immuni.2017.08.009 ↗
63. 10.1007/s00125-018-4777-x10.1007/s00125-018-4777-x ↗
64. 10.1038/s42255-018-0003-x10.1038/s42255-018-0003-x ↗
65. 10.1016/j.cell.2014.05.01210.1016/j.cell.2014.05.012 ↗
66. 10.1172/JCI9035010.1172/JCI90350 ↗
67. 10.1016/j.cell.2017.08.03510.1016/j.cell.2017.08.035 ↗
68. 10.1038/s41598-020-77096-w10.1038/s41598-020-77096-w ↗
69. 10.1126/science.aav372210.1126/science.aav3722 ↗
70. 10.1016/S0021-9258(18)70910-110.1016/S0021-9258(18)70910-1 ↗
71. 10.3390/ijms2013331410.3390/ijms20133314 ↗
72. 10.1530/JME-15-031610.1530/JME-15-0316 ↗
73. 10.1038/3509313110.1038/35093131 ↗
74. 10.1128/MCB.10.7.335710.1128/MCB.10.7.3357 ↗
75. 10.1038/nrm307210.1038/nrm3072 ↗
76. 10.1089/dna.1998.17.96710.1089/dna.1998.17.967 ↗
77. 10.1038/nature0166710.1038/nature01667 ↗
78. 10.1073/pnas.073087010010.1073/pnas.0730870100 ↗
79. 10.1101/gad.113810410.1101/gad.1138104 ↗
80. 10.1042/bj2002166510.1042/bj20021665 ↗
81. 10.1172/JCI6606210.1172/JCI66062 ↗
82. 10.1124/jpet.108.14700910.1124/jpet.108.147009 ↗
83. 10.1007/s00125-006-0481-310.1007/s00125-006-0481-3 ↗
84. 10.1006/bbrc.2001.626510.1006/bbrc.2001.6265 ↗
85. 10.1073/pnas.023710610010.1073/pnas.0237106100 ↗
86. 10.1172/JCI9291310.1172/JCI92913 ↗
87. 10.1016/j.yexcr.2011.10.00110.1016/j.yexcr.2011.10.001 ↗
88. 10.1016/j.cell.2020.11.01410.1016/j.cell.2020.11.014 ↗
89. 10.1016/j.cmet.2020.07.00210.1016/j.cmet.2020.07.002 ↗
90. 10.1111/dom.1295810.1111/dom.12958 ↗
91. 10.1007/s00125-017-4354-810.1007/s00125-017-4354-8 ↗
92. 10.3390/nu1212371910.3390/nu12123719 ↗
93. 10.1016/j.ebiom.2019.11.05110.1016/j.ebiom.2019.11.051 ↗
94. 10.1111/nyas.1410710.1111/nyas.14107 ↗
95. 10.1007/s00125-020-05268-410.1007/s00125-020-05268-4 ↗
96. 10.4239/wjd.v11.i7.29310.4239/wjd.v11.i7.293 ↗
97. 10.1126/science.aad350310.1126/science.aad3503 ↗
98. 10.1038/nature2597310.1038/nature25973 ↗
99. 10.1016/j.ceca.2011.08.00510.1016/j.ceca.2011.08.005 ↗
100. 10.2174/15733991380414322510.2174/157339913804143225 ↗